Challenges of Multidrug-Resistant Tuberculosis Meningitis: Current Treatments and the Role of Glutathione as an Adjunct Therapy
Mohammad J Nasiri, Kabir Lutfy, Vishwanath Venketaraman, Tony W Ng, Steven A Porcelli · 2024
Read Challenges of Multidrug-Resistant Tuberculosis Meningitis: Current Treatments and the Role of Glutathione as an Adjunct Therapy by Mohammad J Nasiri, Kabir Lutfy, Vishwanath Venketaraman, Tony W Ng, Steven A Porcelli (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11728556.txt.
Description
Mohammad Nasiri and co-authors review, in a 2024 paper, the hard problem of drug-resistant tuberculosis that reaches the brain. Meningitis from this infection kills at high rates and leaves lasting nerve damage. Resistance and the germ's immune tricks make it worse.
Standard drugs often penetrate the brain poorly, and treatment runs long with heavy side effects. The review weighs current treatments for this resistant form. It gives special attention to glutathione and to cytokine-based add-on therapies that support the immune system. Lung tuberculosis draws most research money, the authors note. Their review argues the brain form needs its own strategy, not leftovers.
Catalog record
| CREATOR | Mohammad J Nasiri, Kabir Lutfy, Vishwanath Venketaraman, Tony W Ng, Steven A Porcelli |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |